Opinion statement The dissemination of positron emission tomography (PET) technology
has enabled a functional approach to the evaluation of lung cancer that complements the …

Positron emission tomography (PET) has been studied for a variety of indications in patients
with known or suspected non–small-cell lung cancer (NSCLC). This article discusses the …

Positron emission tomography (PET) represents a dramatic advance in the imaging of lung
cancer. It is valuable for the diagnosis, staging, prognosis, and restaging of disease, and is …

Positron emission tomography imaging is useful for the characterization of the solitary
pulmonary nodule and mediastinal staging. Potential future applications include …

18 FDG-PET is an imagining technique based on metabolic criteria rather than
morphological criteria.(18) FDG-PET can demonstrate accelerated glycosis in cancer tissue …

T HE 1990s marked the emergence of positron emission tomography (PET) using F-18
fluorodeoxyglucose (FDG) as the single most powerful imaging tool in the diagnosis and …

Background: Positron emission tomography (PET) has been reported as being useful in the
assessment of indeterminate pulmonary nodules found on thoracic computed tomography …

Lung cancer is the leading cause of death from cancer in both men and women. The
presence of distant metastases or metastases to mediastinal lymph nodes has a significant …

Since its introduction in 1974, positron emission tomography (PET) has gained widespread
use, especially in diagnosis and staging of lung cancer. In this respect, 18F …

Abstract 18 F-fluorodeoxyglucose positron emission tomography (FDG-PET) is a useful
technique to characterize the solitary pulmonary nodule, diagnose primary lung cancer …